Chromo Laboratories India Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is LEVOCETIRIZINE DIHYDROCHLORIDE USP, with a corresponding US DMF Number 33219.
Remarkably, this DMF maintains an Active status since its submission on March 16, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 04, 2024, and payment made on September 29, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II